Skip to content

Acute optic neuritis study: a monocentric, prospective observational study on symptomatology, diagnosis, therapy and prognosis of acute optic neuritis.

Acute optic neuritis study: a monocentric, prospective observational study on symptomatology, diagnosis, therapy and prognosis of acute optic neuritis. - AON-S

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00027095
Enrollment
230
Registered
2021-11-09
Start date
2022-01-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H46 G35 G36.0

Interventions

Group 1: The following data will be collected on a study basis: Medical history, questionnaires on affective disorders (BDI-II) and on visual quality of life (NEI-VFQ-25 with neurovisual supplement),

Sponsors

Experimental and Clinical Research Center (ECRC), AG Klinische Neuroimmunologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Diagnosis of acute optic neuritis - 18 years and older - Person capable of giving consent - Person has health insurance (for clarification of possible incidental findings) - Written consent to participate in the present study

Exclusion criteria

Exclusion criteria: Pregnancy at study inclusion, Relevant concomitant condition considered limiting to study feasibility (e.g., reduced general health due to comorbidities, obesity per magna, acute need for treatment for mental illness, dementia-related syndrome), Insufficient ability to cooperate

Design outcomes

Primary

MeasureTime frame
The aim of the data collection is a prospective follow-up of patients with acute optic neuritis.

Secondary

MeasureTime frame
Descriptive characterization of acute optic neuritis of different etiology and its course during the observation period, both at the level of structural tissue changes, at the level of immunological functions, at the level of symptoms and function, and at the level of subjective effects and possible modifiers of disease progression.

Countries

Germany

Contacts

Public ContactSusanna Asseyer

Experimental and Clinical Research Center (ECRC), AG Klinische Neuroimmunologie

susanna.asseyer@charite.de030/450 539 040

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026